• Home
  • Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).

Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).

Author List
Sara Nunnery, Dorothy Wang, Marisela Tan, Richard Fong, Mimi Ming Lo, Rebecca L. Olin
Publication
Journal of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/79293811
Publication Year
2018
Publication Title
Sara Nunnery, Dorothy Wang, Marisela Tan, Richard Fong, Mimi Ming Lo, Rebecca L. Olin. Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML). Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):e19009-e19009.